Qualigen Therapeutics
QLGN
QLGN
26 hedge funds and large institutions have $5.05M invested in Qualigen Therapeutics in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
15% less call options, than puts
Call options by funds: $87K | Put options by funds: $102K
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Holders
26
Holding in Top 10
–
Calls
$87K
Puts
$102K
Top Buyers
| 1 | +$1.44M | |
| 2 | +$227K | |
| 3 | +$208K | |
| 4 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$43.6K |
| 5 |
BlackRock
New York
|
+$30.9K |
Top Sellers
| 1 | -$369K | |
| 2 | -$158K | |
| 3 | -$97K | |
| 4 |
Vontobel Holding
Zurich,
Switzerland
|
-$68K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$49K |